Comorbidities at MS Diagnosis and Their Association With Treatment Persistence: Real‐World Clinical Data
Comorbidities, especially psychiatric diseases, are associated with lower persistence on injectable DMTs. As comorbidities complicate the treatment of RRMS, it is crucial to identify their role from early on.
Authors
- Mervi Ryytty (ORCID: https://orcid.org/0009-0003-3814-371X)
- Henrik Ahvenjärvi (ORCID: https://orcid.org/0000-0003-3641-3504)
- Johanna Krüger
- Ida Lund
- Anne M. Portaankorva
Institutions
- University of Helsinki (FI)
- Oulu University Hospital (FI)
- University of Oulu (FI)
Publication Details
- Journal
- Brain and Behavior
- Published
- 2026-02-01
- DOI
- https://doi.org/10.1002/brb3.71253
- Primary Topic
- Multiple Sclerosis Research Studies
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Suomen Kulttuurirahasto
- Oulun Yliopisto
- Oulun Yliopiston Tukisäätiö